T3	intervention-participants 881 887	Thirty
T4	intervention-participants 920 922	50
T5	control-participants 1065 1076	Forty eight
T6	control 1077 1093	healthy controls
T7	eligibility 682 775	postmenopausal BC patients who were, following doxorubicin/cyclophosphamide (AC) chemotherapy
T8	outcome 1129 1146	Memory complaints
T9	iv-bin-percent 1164 1167	28%
T10	iv-bin-percent 1191 1194	24%
T11	cv-bin-percent 1222 1224	6%
T12	outcome 1425 1443	verbal functioning
T13	outcome 1503 1514	motor speed
T14	outcome 1591 1605	verbal fluency
T15	outcome 1610 1638	information processing speed
T16	condition 0 30	Neuropsychological functioning
T1	intervention 85 108	tamoxifen or exemestane
